Dr. Alexandra Dubinskaya Joins Femto's Sensera as Medical Advisor

(TheNewswire)

Femto’s Sensera Combines Intelligent Design, Innovative Technologyand Data Driven Insights to Create Its Smart Feminine WellnessDevice

LOS ANGELES – TheNewswire - JANUARY 22, 2025 - Femto Technologies Inc. (Nasdaq: BCAN )(“ Femto ” or the “ Company ”), a FemTechpioneer and the creator of Sensera , a feminine wellnessproduct, today announced that Dr. Alexandra Dubinskaya has joined thecompany as Medical Advisor for the Sensera brand. Dr. Dubinskaya is aUrogynecologist and Reconstructive Pelvic Surgeon at Cedars Sinai inLos Angeles and a Sexual Medicine Specialist with expertise inmenopause and pelvic health.

Sensera’s Medical Advisor, Urogynecologist,Reconstructive Pelvic Surgeon, and Sexual Medicine Specialist, Dr.Alexandra Dubinskaya, said: “Sexual wellness is an essentialcomponent of overall well-being. Yet, many people are unaware of howto navigate changes in their sexual lives as they age or face healthchallenges. Sensera is the first sexual wellness product to leverageAI to help users better understand and adjust to these changes,ultimately improving quality of life and intimateexperiences.”

Dr. Dubinskaya, along with her colleagues, conductedresearch highlighting the positive impact vibrating devices can haveon sexual function and pelvic floor conditions*. She explained:
“Our study demonstrated that vibrating devices could significantlyimprove sexual function over time. We observed a marked reduction inbothersome symptoms of pelvic organ prolapse, as well as lower painscores. Additionally, patients with lichen sclerosus showed noticeableimprovements in lesion appearance, and the severity of vaginal atrophydecreased. Depression rates were also significantly reduced,underscoring the holistic benefits these devices can offer.”

The findings underscore Femto’s mission to integrateinnovation with care, empowering individuals to take charge of theirintimate health and well-being.

“We are thrilled to welcome Dr. Dubinskaya to theSensera team,” said Yftah Ben Yaackov, CEO of Femto. “Herunparalleled knowledge and expertise in the area of sexual function,menopause and pelvic floor health is an asset to the company and tothe women who are looking to Sensera to provide intelligent productsthat bridge the gap between pleasure and wellness.”

Femto’s proprietary technology enables Sensera, aFemTech device, to provide a unique experience designed to adapt to awoman's changing needs over time. Sensera features the brand’sproprietary technology, Smart Release System (SRS), along withbiofeedback sensors, machine learning and artificial intelligence,personalizing the feminine usability experience and enhancingcomfort.

How It Works:

Sensera’s feminine wellness device is made from soft,medical-grade silicone and features a Y-shaped, ergonomic design.Women can choose a capsule (pleasure or wellness) and insert one ofthe interchangeable pods into the device with a simple twist. Once thesession starts, Sensera’s proprietary SRS technology utilizesbiofeedback sensors that track key body metrics, heart rate, andpelvic floor muscle contractions, to adapt to women's personal needsand preferences.

A corresponding iOS app enables users to createpersonal customized programs, enhancing its performance and ability to“build” on previous sessions.

Under strict privacy protocols, women have the choiceto support women’s wellness by sharing their likes, dislikes andfeedback to create better, more personalized wellness programs forall. Sensera also offers device-only mode andmachine learning-only use. Sensera’s AI capabilities are designed tobecome more advanced in correlation to the increased volume of usersand magnitude of fed data.

Sensera’s feminine wellness device includes acharging cable, storage sachet, quick start guide and threeinterchangeable pods: two pleasure; one wellness. It will be availablefor pre-order in Q1 at www.senserawellness.com . Additionalcapsules can be purchased separately as a one-time order or viasubscription. Pre-orders are scheduled to ship early Q2 2025.

###

ABOUT SENSERA

Sensera is a feminine wellness device on a mission tobridge the gap between feminine pleasure and wellness, providing aholistic self-care experience that adapts to a woman’s changingneeds. Sensera utilizes Femto’s proprietary Smart Release System(SRS) technology, including machine learning and AI, to enhancefeminine wellness. Sensera is a CES Innovation Awards® 2025 Honoraryin the AI category.

For more information on Sensera, please visit www.senserawellness.com and followus on Instagram , , and .

ABOUT FEMTO TECHNOLOGIES, INC.

Femto Technologies Inc. (Nasdaq: BCAN), previouslyknown as BYND Cannasoft Enterprises Inc., is a public Femtech company,pioneering a transformative change in the sphere of female wellness.Its proprietary Smart Release System (SRS technology) is embedded inSensera, which has been named CES Innovation Awards® 2025 honoree inthe AI category. Femto’s SRS technology is driving its R&Dactivities and product manufacturing for a variety of Femtechproducts.

The devices described in this news release are conceptdevices that are in the first stage of development and will be subjectto testing, experiments and regulatory approvals and therefore thereis no certainty that they will eventually be marketed.

For more information, please visit www.femtocorp.comand on SEDAR+: www.sedarplus.ca

MEDIA CONTACT

For product demonstration andmedia

Samantha Breen

Opportunity PR (for Sensera)

samantha@opportunitypr.com

+1 949.290.2834

COMPANY CONTACT

Gabi Kabazo

Chief Financial Officer

Tel: (604) 833-6820

e?mail: ir@femtocorp.com

* Sensera’s device was not usedin this study. Dr. Dubinskaya had no relationship with Sensera whenthis research was conducted.

Sensera encourages you to do your own research and readthe full study linked above. This is not intended as medical advice.Discuss any concerns you may have with your doctor.

Cautionary NoteRegarding Forward-Looking Statements

This press release includes certain statements that maybe deemed “forward-looking statements” within the meaning ofSection 27A of the U.S. Securities Act of 1933, as amended, andSection 21E of the U.S. Securities Exchange Act of 1934, as amendedand under Canadian securities laws. When used in this press release,the words “may”, “would”, “could”, “will”,“intend”, “plan”, “anticipate”, “believe”,“estimate”, “expect” and similar expressions are intended toidentify forward?looking statements. Such statements are subject tocertain risks and uncertainties, and actual circumstances, events orresults may differ materially from those projected in suchforward-looking statements.

Although the Company believes the expectationsexpressed in such forward-looking statements are based on reasonableassumptions, such statements are not guarantees of future performance,and actual events or developments may differ materially from those inforward-looking statements. Such forward-looking statementsnecessarily involve known and unknown risks and uncertainties, whichmay cause the Company’s actual performance and financial results infuture periods to differ materially from any projections of futureperformance or results expressed or implied by such forward-lookingstatements. Such statements reflect the Company's current views withrespect to future events and are subject to such risks anduncertainties. Many factors could cause actual results to differmaterially from the statements made, including future financialperformance, unanticipated regulatory requests and delays, finalpatents approval, timing of the Sensera pre-order and those factorsdiscussed in filings made by the company with the Canadian securitiesregulatory authorities, including (without limitation) in thecompany's management's discussion and analysis for the year endedDecember 31, 2023 and annual information form dated April 2, 2024,which are available under the company's profile at www.sedarplus.ca,and in the Company’s Annual Report on Form 20-F for the year thenended that was filed with the U.S. Securities and Exchange Commissionon April 3, 2024. Should one or more of these factors occur, or shouldassumptions underlying the forward-looking statements prove incorrect,actual results may vary materially from those described herein asintended, planned, anticipated, or expected. We do not intend and donot assume any obligation to update these forward?lookingstatements, except as required by law. Any such forward-lookingstatements represent management's estimates as of the date of thispress release. While we may elect to update such forward-lookingstatements at some point in the future, we disclaim any obligation todo so, even if subsequent events cause our views to change.Shareholders are cautioned not to put undue reliance on suchforward?looking statements.

Copyright (c) 2025 TheNewswire - All rights reserved.